Neonatologia
Optymalizacja i utrzymanie hemostazy
Rekombinowany aktywowany czynnik VII (rFVIIa)
Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. (opens new window)
Źródło: Paediatr Anaesth 2006;16(10):1042-6.
Indeks: PubMed 16972833
DOI: 10.1111/j.1460-9592.2006.02039.x
https://www.ncbi.nlm.nih.gov/pubmed/16972833 (opens new window)
The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. (opens new window)
Źródło: Blood Coagul Fibrinolysis 2006;17(3):213-6.
Indeks: PubMed 16575260
DOI: 10.1097/01.mbc.0000220245.20036.2d
https://www.ncbi.nlm.nih.gov/pubmed/16575260 (opens new window)
The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. (opens new window)
Źródło: Pediatrics 2002;110(1 Pt 1):169-71.
Indeks: PubMed 12093965
https://www.ncbi.nlm.nih.gov/pubmed/12093965 (opens new window)
Recombinant activated factor VIIa (rFVIIa) treatment in very-low-birth-weight (VLBW) premature infants with acute pulmonary hemorrhage: a single-center, retrospective study. (opens new window)
Źródło: Paediatr Drugs 2017;19(1):53-8.
Indeks: PubMed 27826851
DOI: 10.1007/s40272-016-0203-3
https://www.ncbi.nlm.nih.gov/pubmed/27826851 (opens new window)
Recombinant activated factor VIIa treatment for refractory hemorrhage in infants. (opens new window)
Źródło: J Perinatol 2011;31(3):188-92.
Indeks: PubMed 20671714
DOI: 10.1038/jp.2010.85
https://www.ncbi.nlm.nih.gov/pubmed/20671714 (opens new window)
Use of recombinant factor VIIa in infants with severe coagulopathy. (opens new window)
Źródło: J Perinatol 2004;24(5):310-1.
Indeks: PubMed 15116125
DOI: 10.1038/sj.jp.7211086
https://www.ncbi.nlm.nih.gov/pubmed/15116125 (opens new window)
Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbances. (opens new window)
Źródło: J Pediatr Hematol Oncol 2013;35(3):221-6.
Indeks: PubMed 23511491
DOI: 10.1097/MPH.0b013e318286d27e
https://www.ncbi.nlm.nih.gov/pubmed/23511491 (opens new window)
Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage. (opens new window)
Źródło: Blood Coagul Fibrinolysis 2006;17(5):413-5.
Indeks: PubMed 16788319
DOI: 10.1097/01.mbc.0000233373.71970.6f
https://www.ncbi.nlm.nih.gov/pubmed/16788319 (opens new window)
Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (opens new window)
Źródło: Paediatr Anaesth 2009;19(4):364-70.
Indeks: PubMed 19143947
DOI: 10.1111/j.1460-9592.2008.02905.x
https://www.ncbi.nlm.nih.gov/pubmed/19143947 (opens new window)
The use of recombinant factor VIIa for severe intractable bleeding during spine surgery. (opens new window)
Źródło: Spine 2004;29(12):1384-7.
Indeks: PubMed 15187645
https://www.ncbi.nlm.nih.gov/pubmed/15187645 (opens new window)
Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases. (opens new window)
Źródło: J Pediatr Hematol Oncol 2007;29(3):145-50.
Indeks: PubMed 17356391
DOI: 10.1097/MPH.0b013e3180335bcb
https://www.ncbi.nlm.nih.gov/pubmed/17356391 (opens new window)
Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. (opens new window)
Źródło: J Perinatol 2002;22(8):672-4.
Indeks: PubMed 12478454
DOI: 10.1038/sj.jp.7210787
https://www.ncbi.nlm.nih.gov/pubmed/12478454 (opens new window)
Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma. (opens new window)
Źródło: Pediatr Blood Cancer 2009;53(6):1074-8.
Indeks: PubMed 19621430
DOI: 10.1002/pbc.22160
https://www.ncbi.nlm.nih.gov/pubmed/19621430 (opens new window)